Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.47 USD | +4.39% | +1.11% | +11.86% |
Apr. 29 | Transcript : Capricor Therapeutics, Inc. - Special Call | |
Apr. 24 | Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.86% | 172M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.41% | 22.94B | |
-12.15% | 22.34B | |
-5.75% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Capricor Secures Meeting With FDA on CAP-1002 Manufacturing Plans; Shares Rise